These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

366 related items for PubMed ID: 18405411

  • 21. Clinical predictors of duration of action of cisatracurium and rocuronium administered long-term.
    Fassbender P, Geldner G, Blobner M, Hofmockel R, Rex C, Gautam S, Malhotra A, Eikermann M.
    Am J Crit Care; 2009 Sep; 18(5):439-45. PubMed ID: 19723864
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Reversal of profound neuromuscular block by sugammadex administered three minutes after rocuronium: a comparison with spontaneous recovery from succinylcholine.
    Lee C, Jahr JS, Candiotti KA, Warriner B, Zornow MH, Naguib M.
    Anesthesiology; 2009 May; 110(5):1020-5. PubMed ID: 19387176
    [Abstract] [Full Text] [Related]

  • 26. Comparative study on the pharmacodynamics of cisatracurium: continuous infusion or intermittent bolus injection.
    Dong YJ, Li X.
    Contemp Clin Trials; 2012 May; 33(3):482-5. PubMed ID: 22269820
    [Abstract] [Full Text] [Related]

  • 27. Rocuronium 0.3 mg x kg-1 (ED95) induces a normal peak effect but an altered time course of neuromuscular block in patients with Duchenne's muscular dystrophy.
    Muenster T, Schmidt J, Wick S, Forst J, Schmitt HJ.
    Paediatr Anaesth; 2006 Aug; 16(8):840-5. PubMed ID: 16884467
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Neuromuscular pharmacodynamics of rocuronium in patients with major burns.
    Han T, Kim H, Bae J, Kim K, Martyn JA.
    Anesth Analg; 2004 Aug; 99(2):386-92, table of contents. PubMed ID: 15271712
    [Abstract] [Full Text] [Related]

  • 30. A comparison of tubocurarine, rocuronium, and cisatracurium in the prevention and reduction of succinylcholine-induced muscle fasciculations.
    True CA, Carter PJ.
    AANA J; 2003 Feb; 71(1):23-8. PubMed ID: 12776646
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Cisatracurium versus vecuronium: a comparative, double blind, randomized, multicenter study in adult patients under propofol/fentanyl/N2O anesthesia.
    Melloni C, Devivo P, Launo C, Mastronardi P, Novelli GP, Romano E.
    Minerva Anestesiol; 2006 May; 72(5):299-308. PubMed ID: 16675938
    [Abstract] [Full Text] [Related]

  • 33. Antagonism of profound cisatracurium and rocuronium block: the role of objective assessment of neuromuscular function.
    Kopman AF, Kopman DJ, Ng J, Zank LM.
    J Clin Anesth; 2005 Feb; 17(1):30-5. PubMed ID: 15721727
    [Abstract] [Full Text] [Related]

  • 34. Sugammadex reversal of rocuronium-induced neuromuscular blockade: a comparison with neostigmine-glycopyrrolate and edrophonium-atropine.
    Sacan O, White PF, Tufanogullari B, Klein K.
    Anesth Analg; 2007 Mar; 104(3):569-74. PubMed ID: 17312210
    [Abstract] [Full Text] [Related]

  • 35. Effects of ephedrine on the onset time of neuromuscular block and intubating conditions after cisatracurium: preliminary results.
    Albert F, Hans P, Bitar Y, Brichant JF, Dewandre PY, Lamy M.
    Acta Anaesthesiol Belg; 2000 Mar; 51(3):167-71. PubMed ID: 11129616
    [Abstract] [Full Text] [Related]

  • 36. Reversal of profound, high-dose rocuronium-induced neuromuscular blockade by sugammadex at two different time points: an international, multicenter, randomized, dose-finding, safety assessor-blinded, phase II trial.
    Pühringer FK, Rex C, Sielenkämper AW, Claudius C, Larsen PB, Prins ME, Eikermann M, Khuenl-Brady KS.
    Anesthesiology; 2008 Aug; 109(2):188-97. PubMed ID: 18648227
    [Abstract] [Full Text] [Related]

  • 37. Tracheal intubating conditions and pharmacodynamics following cisatracurium in infants and children undergoing halothane and thiopental-fentanyl anesthesia.
    Meakin GH, Meretoja OA, Perkins RJ, Waite I, Taivainen T, Wirtavuori K, Murphy AK, Raiha L.
    Paediatr Anaesth; 2007 Feb; 17(2):113-20. PubMed ID: 17238881
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. A comparison of the efficacy of cisatracurium and atracurium in kidney transplantation operation.
    Jirasiritham S, Tantivitayatan K, Jirasiritham S.
    J Med Assoc Thai; 2004 Jan; 87(1):73-9. PubMed ID: 14971538
    [Abstract] [Full Text] [Related]

  • 40. A comparison of the onset and clinical duration of high doses of cisatracurium and rocuronium.
    Lighthall GK, Jamieson MA, Katolik J, Brock-Utne JG.
    J Clin Anesth; 1999 May; 11(3):220-5. PubMed ID: 10434218
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 19.